HCPLive Network


| Thursday, January 01, 1970

The true cost of Obamacare was recently revealed in the pages of a new Congressional Budget Office report. The total bill for the president’s program is estimated to reach $1.9 trillion over the next 10 years.
The US economy is growing at a pace not seen in the last decade, yet the stock market is caught in a web of uncertainty that has little chance of clearing up in the months ahead. In such times, the prudent choice is to stick with quality stocks like these.
Big data is increasingly having an impact on the way physicians practice medicine. Now a new tool is leveraging crowdsourced data to help doctors make smarter career choices.
Implantable cardioverter-defibrillators (ICDs) have prevented cardiac arrests and deaths, but they carry a risk of giving patients shocks when they don’t need them. That inappropriate shock rate has been estimated as occurring in 10 to 20% of patients with the devices, causing unnecessary hospital admissions, and a negative impact on patients’ quality of life. They are also associated with increased morbidity and mortality for some patients. But in a study in Heart Rhythm Angelo Auricchio, MD, PhD, and colleagues report on technological improvements in a Medtronic device that has reduced those shocks to 1.5% with a dual/triple chamber defibrillator and 2.5% for a single chamber ICD after one year.
Just 3 days before the state hosts the nation’s biggest sporting event, public health officials in Arizona are locked in an off-the-field battle with a different kind of opponent.
Phosphodiesterase type 5 inhibitor use after radical prostatectomy is associated with increased risk of biochemical recurrence, according to a study published in the February issue of The Journal of Urology.